Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Rosario F. DI STEFANO"'
Autor:
Maria Lucia Reale, Paolo Bironzo, Valentina Bertaglia, Erica Palesandro, Gianmarco Leone, Fabrizio Tabbò, Maristella Bungaro, Marco Audisio, Annapaola Mariniello, Simonetta G. Rapetti, Rosario F. Di Stefano, Elisa Artusio, Enrica Capelletto, Paola Sperone, Adriana Boccuzzi, Marco Calandri, Alberto Perboni, Umberto Malapelle, Francesco Passiglia, Silvia Novello
Publikováno v:
Frontiers in Oncology, Vol 10 (2020)
Background: The world, and Italy on the front lines, has experienced a major medical emergency due to the novel coronavirus outbreak. Cancer patients are one of the potentially most vulnerable cohorts of people, but data about their management are st
Externí odkaz:
https://doaj.org/article/e9ecd82886084413aaef5456723e9a96
Autor:
Laura Bergamasco, Adriana Boccuzzi, Franco Riccardini, Rossana Cavallo, Marta Greco, Clara Piatti, Carlotta Geninatti, Paolo Fonio, Marco Calandri, Rosario F Di Stefano, Giorgio Limerutti, Ambra Santonocito, Andrea Veltri, Stephanie Gentile, Vittorio Morrone, Sara Varello, Riccardo Faletti, Andrea Biondo, Marco Gatti, Matteo Barba
Publikováno v:
La Radiologia Medica
La radiologia medica
La radiologia medica
Purpose To assess the reliability of CXR and to describe CXR findings and clinical and laboratory characteristics associated with positive and negative CXR. Methods Retrospective two-center study on consecutive patients admitted to the emergency depa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b158d52dd304f323bb4192a96fca6c43
http://europepmc.org/articles/PMC7475717
http://europepmc.org/articles/PMC7475717
Autor:
Tiziana ANGUSTI, Rosario F. DI STEFANO, Antonella PARENTE, Maristella BUNGARO, Fabio TURCO, Alessandro SAMUELLY, Chiara PISANO, Giorgio V. SCAGLIOTTI, Massimo DI MAIO, Marcello TUCCI, Consuelo BUTTIGLIERO
Our study aims to identify baseline prognostic factors in metastatic castration resistant prostate cancer (mCRPC) patients treated with Radium-223.Data about demographics, ECOG performance status, lymph node (LN) involvement, local treatment for pros
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::42dee94a91d18fd006e0e8d58b576db0
http://hdl.handle.net/2318/1849329
http://hdl.handle.net/2318/1849329
Autor:
Fabio Turco, Giorgio V. Scagliotti, Rosario F Di Stefano, Massimo Di Maio, C. Pisano, Consuelo Buttigliero, Marcello Tucci, Marco Audisio, Alessandro Samuelly, Maristella Bungaro
Publikováno v:
Endocrine-related cancer. 28(7)
Obesity represents a well-known risk factor for renal cell carcinoma development. Several studies evaluated the relationship between obesity and outcome in patients with non-metastatic and metastatic renal cell carcinoma using different parameters su
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::60d292d66b08639878fcaf0bb118b012
https://pubmed.ncbi.nlm.nih.gov/33949971
https://pubmed.ncbi.nlm.nih.gov/33949971
Autor:
Fabio Turco, Francesca Vignani, Massimo Di Maio, Maristella Bungaro, Marcello Tucci, Federica Tarenghi, Alessandro Samuelly, Consuelo Buttigliero, Giorgio V. Scagliotti, Rosario F Di Stefano, C. Pisano
Publikováno v:
Minerva urology and nephrology. 73(6)
BACKGROUND Platelet-to-lymphocyte ratio (PLR) and neutrophil-to-lymphocyte ratio (NLR) are markers of systemic inflammation associated with poor outcome in several solid tumours. We retrospectively investigated the prognostic role of PLR and, secondl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::793c3af7223d0e62a4cbcf7aedf43e39
https://pubmed.ncbi.nlm.nih.gov/33781017
https://pubmed.ncbi.nlm.nih.gov/33781017
Autor:
Marcello Tucci, Consuelo Buttigliero, Enrico Bollito, Fabio Turco, Alessandro Samuelly, Giorgio V. Scagliotti, Maristella Bungaro, Rosario F Di Stefano
Testicular metastases from renal cell carcinoma (RCC) are extremely rare. Tyrosine kinase inhibitors (TKI) are the cornerstone of systemic therapy for metastatic RCC. We report a case of testicular metastasis in a 72-year-old patient with RCC that de
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::582bca49f0c811e47cf6e93e38884c62
http://hdl.handle.net/2318/1849339
http://hdl.handle.net/2318/1849339
Autor:
Rosario F Di Stefano, Giorgio V. Scagliotti, Francesca Vignani, C. Pisano, Maristella Bungaro, Marcello Tucci, Consuelo Buttigliero, Fabio Turco, Massimo Di Maio, Mara Gallicchio, Alessandro Samuelly
Our retrospective study aims to evaluate the prognostic role of duration of response to androgen deprivation therapy (ADT) in metastatic castration resistant prostate cancer (mCRPC) patients treated with enzalutamide (E) or abiraterone acetate (AA).D
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ec3be8014d65a0760e4a836c0290376a
http://hdl.handle.net/2318/1793539
http://hdl.handle.net/2318/1793539
Autor:
Gianmauro Numico, Pamela Guglielmini, Marcello Tucci, Rosario F Di Stefano, Giorgio V. Scagliotti, Massimo Di Maio, Francesca Vignani, Fabio Turco, C. Pisano, Gaetano Lacidogna, Consuelo Buttigliero, Cristina Sonetto
Publikováno v:
Minerva Urologica e Nefrologica. 72
BACKGROUND Previous studies demonstrated a predictive value of prostate-specific antigen (PSA) kinetics for treatment outcome. Our retrospective study evaluates the prognostic role of early PSA drop in metastatic castration resistant prostate cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eca25485ebb4982b96ee8d3cf9558f6c
https://doi.org/10.23736/s0393-2249.20.03708-x
https://doi.org/10.23736/s0393-2249.20.03708-x
Autor:
Rosario F Di Stefano, Francesca Vignani, Consuelo Buttigliero, Marcello Tucci, Maria Lucia Reale, Massimo Di Maio
Publikováno v:
Translational Cancer Research. 7:S611-S615
For prostate cancer as for many other solid tumors, cancer treatments are constantly and rapidly evolving. The primary goals remain, however, the same: to allow patients to live longer and to live better (1). Clinical benefit integrates, in fact, tre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::efbde66b90430347d67c6799fb5c74af
https://doi.org/10.21037/tcr.2018.05.29
https://doi.org/10.21037/tcr.2018.05.29
Autor:
Rosario F Di Stefano, Massimo Di Maio, C. Pisano, Marcello Tucci, Fabio Turco, Giorgio V. Scagliotti, Consuelo Buttigliero
Publikováno v:
Critical reviews in oncology/hematology. 157
In last years several improvements have been made in the management of prostate cancer (PCa). Androgen receptor (AR) is considered the main driver in PCa growth and progression and most drugs are directed against AR pathway. Once PCa spreads outside
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1c87c1d4becf081f5013421c85549db8
https://pubmed.ncbi.nlm.nih.gov/33341506
https://pubmed.ncbi.nlm.nih.gov/33341506